newsfilter
← Latest News
GlobeNewswire·

Oyster Point Pharma to Report Third Quarter 2021 Financial Results on November 4, 2021

PRINCETON, N.J., Oct. 28, 2021 (GLOBE NEWSWIRE) -- Oyster Point Pharma, Inc. (NASDAQ:OYST), a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of first-in-class pharmaceutical therapies to treat ocu